Have a personal or library account? Click to login
Comparison between whole-body MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: a systematic review Cover

Comparison between whole-body MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: a systematic review

Radiology and Oncology
Volume 47 (2013): Issue 3 (September 2013)
By: Mario Ciliberto,  Fabio Maggi,  Giorgio Treglia,  Federico Padovano,  Lucio Calandriello,  Alessandro Giordano and  Lorenzo Bonomo  
Open Access
|Jul 2013

References

  1. 1. Hodolic M. Role of F-18-choline PET/CT in evaluation of patients with prostate carcinoma. Radiol Oncol 2011; 45: 17-21.10.2478/v10019-010-0050-8342371422933929
    Search in Google Scholar
  2. 2. Basu S, Alavi A. Unparalleled contribution of 18F-FDG PET to medicine over 3 decades. J Nucl Med 2008; 49: 17N-21N, 37N.
    Search in Google Scholar
  3. 3. Wang X, Xu M, Liang H, Xu LS. Comparison of CT and MRI in diagnosis of cerebrospinal leak induced by multiple fractures of skull base. Radiol Oncol 2011; 45: 91-6.10.2478/v10019-011-0007-6342373422933941
    Search in Google Scholar
  4. 4. Schmidt GP, Reiser MF, Baur-Melnyk A. Whole-body MRI for the staging and follow-up of patients with metastasis. Eur J Radiol 2009; 70: 393-400.10.1016/j.ejrad.2009.03.04519457631
    Search in Google Scholar
  5. 5. Lambregts DM, Maas M, Cappendijk VC, Prompers LM, Mottaghy FM, Beets GL, et al. Whole-body diffusion-weighted magnetic resonance imaging: Current evidence in oncology and potential role in colorectal cancer staging. Eur J Cancer 2011; 47: 2107-16.10.1016/j.ejca.2011.05.01321664810
    Search in Google Scholar
  6. 6. Thomson V, Pialat JB, Gay F, Coulon A, Voloch A, Granier A, et al. Wholebody MRI for metastases screening: a preliminary study using 3D VIBE sequences with automatic subtraction between noncontrast and contrast enhanced images. Am J Clin Oncol 2008; 31: 285-92.10.1097/COC.0b013e31815e3ff418525309
    Search in Google Scholar
  7. 7. Mürtz P, Krautmacher C, Träber F, Gieseke J, Schild HH, Willinek WA. Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla. Eur Radiol 2007; 17: 3031-7.10.1007/s00330-007-0717-817646990
    Search in Google Scholar
  8. 8. Seemann MD, Meisetschlaeger G, Gaa J, Rummeny EJ. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI. Eur J Med Res 2006; 11: 58-65.
    Search in Google Scholar
  9. 9. Furth C, Amthauer H, Denecke T, Ruf J, Henze G, Gutberlet M. Impact of whole-body MRI and FDG-PET on staging and assessment of therapy response in a patient with Ewing sarcoma. Pediatr Blood Cancer 2006; 47: 607-11.10.1002/pbc.2066216261559
    Search in Google Scholar
  10. 10. Yan RZ, Yang C, Zhang Q, Gu XM. [Whole-body diffusion weighted imaging manifestation of oral squamous cell carcinoma with metastatic lymph nodes]. [Chinese]. Zhonghua Kou Qiang Yi Xue Za Zhi 2009; 44: 144-6.
    Search in Google Scholar
  11. 11. Wang JW, Zhao S, Liu Y, Li J, Xu LM. [Preliminary study on the validity of whole body diffusion-weighted imaging for the detection of malignant lesions]. [Chinese]. Zhonghua Kou Qiang Yi Xue Za Zhi 2010; 32: 304-8.
    Search in Google Scholar
  12. 12. Lin C, Luciani A, Itti E, El-Gnaoui T, Vignaud A, Beaussart P, et al. Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma. Eur Radiol 2010; 20: 2027-38.10.1007/s00330-010-1758-y20309558
    Search in Google Scholar
  13. 13. Schmidt GP, Baur-Melnyk A, Tiling R, Hahn K, Reiser MF, Schoenberg SO. [Comparison of high resolution whole-body MRI using parallel imaging and PET-CT. First experiences with a 32-channel MRI system.] [German]. Radiologe 2004; 44: 889-98.
    Search in Google Scholar
  14. 14. Reiner CS, Fischer MA, Hany T, Stolzmann P, Nanz D, Donati OF, et al. Molecular imaging of malignant tumor metabolism: whole-body image fusion of DWI/CT vs. PET/CT. Acad Radiol 2011; 18: 940-6.10.1016/j.acra.2011.03.01021718953
    Search in Google Scholar
  15. 15. Ohno Y, Koyama H, Nogami M, Takenaka D, Yoshikawa T, Yoshimura M, et al. Whole-body MR imaging vs. FDG-PET: comparison of accuracy of M-stage diagnosis for lung cancer patients. J Magn Reson Imaging 2007; 26: 498-509.10.1002/jmri.2103117729341
    Search in Google Scholar
  16. 16. Ng SH, Chan SC, Yen TC, Chang JT, Liao CT, Ko SF, et al. Pretreatment evaluation of distant-site status in patients with nasopharyngeal carcinoma: accuracy of whole-body MRI at 3-Tesla and FDG-PET-CT. Eur Radiol 2009; 19: 2965-76.10.1007/s00330-009-1504-5
    Search in Google Scholar
  17. 17. Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 2003; 290: 3199-206.10.1001/jama.290.24.3199
    Search in Google Scholar
  18. 18. Schmidt GP, Baur-Melnyk A, Herzog P, Schmid R, Tiling R, Schmidt M, et al. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol 2005; 40: 743-53.10.1097/01.rli.0000185878.61270.b0
    Search in Google Scholar
  19. 19. Komori T, Narabayashi I, Matsumura K, Matsuki M, Akagi H, Ogura Y, et al. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/ computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. Ann Nucl Med 2007; 21: 209-15.10.1007/s12149-007-0010-6
    Search in Google Scholar
  20. 20. Li S, Sun F, Jin ZY, Xue HD, Li ML. Whole-body diffusion-weighted imaging: technical improvement and preliminary results. J Magn Reson Imaging 2007; 26: 1139-44.10.1002/jmri.21074
    Search in Google Scholar
  21. 21. Brauck K, Zenge MO, Vogt FM, Quick HH, Stock F, Trarbach T, et al. Feasibility of whole-body MR with T2- and T1-weighted real-time steady-state free precession sequences during continuous table movement to depict metastases. Radiology 2008; 246: 910-6.10.1148/radiol.2463062017
    Search in Google Scholar
  22. 22. Yang TH, Lin JZ, Wang X, Lu JH, Chen Z. Preliminary study of feasibility of whole body diffusion weighted imaging in diagnosis of metastasis of tumor. Chin Med Sci J 2008; 23: 187-92.10.1016/S1001-9294(09)60037-7
    Search in Google Scholar
  23. 23. Stecco A, Romano G, Negru M, Volpe D, Saponaro A, Costantino S, et al. Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncologic patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study. Radiol Med 2009; 114: 1-17.10.1007/s11547-008-0348-419082787
    Search in Google Scholar
  24. 24. Krohmer S, Sorge I, Krausse A, Kluge R, Bierbach U, Marwede D, et al. Whole-body MRI for primary evaluation of malignant disease in children. Eur J Radiol 2010; 74: 256-61.10.1016/j.ejrad.2009.01.03719278802
    Search in Google Scholar
  25. 25. Fischer MA, Nanz D, Hany T, Reiner CS, Stolzmann P, Donati OF, et al. Diagnostic accuracy of whole-body MRI/DWI image fusion for detection of malignant tumours: a comparison with PET/CT. Eur Radiol 2011; 21: 246-55.10.1007/s00330-010-1929-x20717828
    Search in Google Scholar
  26. 26. Schmidt GP, Paprottka P, Jakobs TF, Hoffmann RT, Baur-Melnyk A, Haug A, et al. FDG-PET-CT and whole-body MRI for triage in patients planned for radioembolisation therapy. Eur J Radiol 2012; 81: 269-76.10.1016/j.ejrad.2011.02.01821398060
    Search in Google Scholar
  27. 27. Cafagna D, Rubini G, Iuele F, Maggialetti N, Notaristefano A, Pinto D, et al. Whole-body MR-DWIBS vs. [(18)F]-FDG-PET/CT in the study of malignant tumors: a retrospective study. Radiol Med 2012; 117: 293-311.10.1007/s11547-011-0708-321744252
    Search in Google Scholar
  28. 28. Manenti G, Cicciò C, Squillaci E, Strigari L, Calabria F, Danieli R, et al. Role of combined DWIBS/3D-CE-T1w whole-body MRI in tumor staging: Comparison with PET-CT. Eur J Radiol 2012 doi:10.1016/j.ejrad.2011.08.00510.1016/j.ejrad.2011.08.00521908120
    Search in Google Scholar
  29. 29. Punwani S, Taylor SA, Bainbridge A, Prakash V, Bandula S, De Vita E, et al. Pediatric and adolescent lymphoma: comparison of whole-body STIR half- Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging. Radiology 2010; 255: 182-90.10.1148/radiol.0909110520308456
    Search in Google Scholar
  30. 30. van Ufford HM, Kwee TC, Beek FJ, van Leeuwen MS, Takahara T, Fijnheer R, et al. Newly diagnosed lymphoma: initial results with whole-body T1- weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/ CT. AJR Am J Roentgenol 2011; 196: 662-9.10.2214/AJR.10.474321343511
    Search in Google Scholar
  31. 31. Abdulqadhr G, Molin D, Aström G, Suurküla M, Johansson L, Hagberg H, et al. Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients. Acta Radiol 2011; 52: 173-80.10.1258/ar.2010.10024621498346
    Search in Google Scholar
  32. 32. Gu J, Chan T, Zhang J, Leung AY, Kwong YL, Khong PL. Whole-body diffusionweighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma. AJR Am J Roentgenol 2011; 197: w384-91.10.2214/AJR.10.569221862763
    Search in Google Scholar
  33. 33. Lin C, Itti E, Luciani A, Zegai B, Lin SJ, Kuhnowski F, et al. Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma:pilot study. Invest Radiol 2011; 46: 341-9.10.1097/RLI.0b013e3182087b0321263330
    Search in Google Scholar
  34. 34. Wu X, Kellokumpu-Lehtinen PL, Pertovaara H, Korkola P, Soimakallio S, Eskola H, et al. Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma--a pilot study: comparison with 2-deoxy-2-fluoro-D-glucose-positron emission tomography/ computed tomography. NMR Biomed 2011; 24: 1181-90.10.1002/nbm.168921387451
    Search in Google Scholar
  35. 35. Chen Y, Zhong J, Wu H, Chen N. The clinical application of whole-body diffusion- weighted imaging in the early assessment of chemotherapeutic effects in lymphoma: the initial experience. Magn Reson Imaging 2012; 30: 165-70.10.1016/j.mri.2011.09.01922133288
    Search in Google Scholar
  36. 36. Shortt CP, Gleeson TG, Breen KA, McHugh J, O’Connell MJ, O’Gorman PJ, et al. Whole-Body MRI versus PET in assessment of multiple myeloma disease activity. AJR Am J Roentgenol 2009; 192: 980-6.10.2214/AJR.08.163319304704
    Search in Google Scholar
  37. 37. Daldrup-Link HE, Franzius C, Link TM, Laukamp D, Sciuk J, Jürgens H, et al. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am JRoentgenol 2001; 177: 229-36.10.2214/ajr.177.1.177022911418435
    Search in Google Scholar
  38. 38. Schmidt GP, Schoenberg SO, Schmid R, Stahl R, Tiling R, Becker CR, et al. Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT. Eur Radiol 2007; 17: 939-49.10.1007/s00330-006-0361-816951929
    Search in Google Scholar
  39. 39. Ribrag V, Vanel D, Leboulleux S, Lumbroso J, Couanet D, Bonniaud G, et al. Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy. Eur J Radiol 2008; 66: 325-31.10.1016/j.ejrad.2007.06.01417651934
    Search in Google Scholar
  40. 40. Kumar J, Seith A, Kumar A, Sharma R, Bakhshi S, Kumar R, et al. Wholebody MR imaging with the use of parallel imaging for detection of skeletal metastases in pediatric patients with small-cell neoplasms: comparison with skeletal scintigraphy and FDG PET/CT. Pediatr Radiol 2008; 38: 953-62.10.1007/s00247-008-0921-y18636251
    Search in Google Scholar
  41. 41. Takenaka D, Ohno Y, Matsumoto K, Aoyama N, Onishi Y, Koyama H, et al. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. J Magn Reson Imaging 2009; 30: 298-308.10.1002/jmri.2185819629984
    Search in Google Scholar
  42. 42. Heusner T, Gölitz P, Hamami M, Eberhardt W, Esser S, Forsting M, et al. “One-stop-shop” staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases? Eur J Radiol 2011; 78: 430-5.
    Search in Google Scholar
  43. 43. Ng SH, Chan SC, Yen TC, Liao CT, Chang JT, Ko SF, et al. Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT. Eur Radiol 2010; 20: 2229-40.10.1007/s00330-010-1784-920393714
    Search in Google Scholar
  44. 44. O’Neill JP, Moynagh M, Kavanagh E, O’Dwyer T. Prospective, blinded trial of whole-body magnetic resonance imaging versus computed tomography positron emission tomography in staging primary and recurrent cancer of the head and neck. J Laryngol Otol 2010; 124: 1274-7.10.1017/S002221511000139820537210
    Search in Google Scholar
  45. 45. Ng SH, Chan SC, Yen TC, Liao CT, Lin CY, Tung-Chieh Chang J, et al. PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma. Eur J Nucl Med Mol Imaging 2011; 38: 996-1008.10.1007/s00259-011-1740-121327634
    Search in Google Scholar
  46. 46. Chan SC, Wang HM, Yen TC, Lin CY, Chin SC, Liao CT, et al. 18F-FDG PET/ CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study. Eur J Nucl Med Mol Imaging 2011; 38: 1607-19.10.1007/s00259-011-1824-y21567252
    Search in Google Scholar
  47. 47. Eiber M, Souvatzoglou M, Pickhard A, Loeffelbein DJ, Knopf A, Holzapfel K, et al. Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction. Eur J Radiol 2012; 81: 2658-65.10.1016/j.ejrad.2011.10.00522078793
    Search in Google Scholar
  48. 48. Plathow C, Aschoff P, Lichy MP, Eschmann S, Hehr T, Brink I, et al. Positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced nonsmall cell lung cancer-initial results. Invest Radiol 2008; 43: 290-7.10.1097/RLI.0b013e318163273a18424949
    Search in Google Scholar
  49. 49. Ohno Y, Koyama H, Onishi Y, Takenaka D, Nogami M, Yoshikawa T, et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 2008; 248: 643-54.10.1148/radiol.248207203918539889
    Search in Google Scholar
  50. 50. Yi CA, Shin KM, Lee KS, Kim BT, Kim H, Kwon OJ, et al. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. Radiology 2008; 248: 632-42.
    Search in Google Scholar
  51. 51. Chen W, Jian W, Li HT, Li C, Zhang YK, Xie B, et al. Whole-body diffusionweighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up? Magn Reson Imaging 2010; 28: 613-70.10.1016/j.mri.2010.02.00920418042
    Search in Google Scholar
  52. 52. Pfannenberg C, Aschoff P, Schanz S, Eschmann SM, Plathow C, Eigentler TK, et al. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer 2007; 43: 557-64.10.1016/j.ejca.2006.11.01417224266
    Search in Google Scholar
  53. 53. Laurent V, Trausch G, Bruot O, Olivier P, Felblinger J, Régent D. Comparative study of two whole-body imaging techniques in the case of melanoma metastases: advantages of multi-contrast MRI examination including a diffusion-weighted sequence in comparison with PET-CT. Eur J Radiol 2010; 75: 376-83.10.1016/j.ejrad.2009.04.05919497694
    Search in Google Scholar
  54. 54. Dellestable P, Granel-Brocard F, Rat AC, Olivier P, Régent D, Schmutz JL. [Impact of whole body magnetic resonance imaging (MRI) in the management of melanoma patients, in comparison with positron emission tomography/ computed tomography (TEP/CT) and CT.] [French]. Ann DermatolVenereol 2011; 138: 377-83.
    Search in Google Scholar
  55. 55. Schmidt GP, Baur-Melnyk A, Haug A, Heinemann V, Bauerfeind I, Reiser MF, et al. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT. Eur J Radiol 2008; 65: 47-58.10.1016/j.ejrad.2007.10.02118082989
    Search in Google Scholar
  56. 56. Heusner TA, Kuemmel S, Koeninger A, Hamami ME, Hahn S, Quinsten A, et al. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging. Eur JNucl Med Mol Imaging 2010; 37: 1077-86.10.1007/s00259-010-1399-z20204355
    Search in Google Scholar
  57. 57. Squillaci E, Manenti G, Mancino S, Cicciò C, Calabria F, Danieli R, et al. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience. Abdom Imaging 2008; 33: 676-88.10.1007/s00261-007-9347-518373114
    Search in Google Scholar
  58. 58. Schmidt GP, Baur-Melnyk A, Haug A, Utzschneider S, Becker CR, Tiling R, et al. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. EurRadiol 2009; 19: 1366-78.
    Search in Google Scholar
  59. 59. Giraudet AL, Vanel D, Leboulleux S, Aupérin A, Dromain C, Chami L, et al. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. J Clin Endocrinol Metab 2007; 92: 4185-90.10.1210/jc.2007-121117726071
    Search in Google Scholar
  60. 60. Takano A, Oriuchi N, Tsushima Y, Taketomi-Takahashi A, Nakajima T, Arisaka Y, et al. Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy. Ann Nucl Med 2008; 22: 395-401.10.1007/s12149-008-0128-118600417
    Search in Google Scholar
  61. 61. Plathow C, Walz M, Lichy MP, Aschoff P, Pfannenberg C, Bock H, et al. [Cost considerations for whole-body MRI and PET/CT as part of oncologic staging.] [German]. Radiologe 2008; 48: 384-96.10.1007/s00117-007-1547-z17891370
    Search in Google Scholar
DOI: https://doi.org/10.2478/raon-2013-0007 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 206 - 218
Published on: Jul 30, 2013
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
positron emission tomography,
PET/CT,
fluorodeoxyglucose,
whole-body magnetic resonance imaging,
diffusion-weighted imaging,
oncology
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2013 Mario Ciliberto, Fabio Maggi, Giorgio Treglia, Federico Padovano, Lucio Calandriello, Alessandro Giordano, Lorenzo Bonomo, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Previous articleVolume 47 (2013): Issue 3 (September 2013)Next article